Logo image of CCL-B.CA

CCL INDUSTRIES INC - CL B (CCL-B.CA) Stock Fundamental Analysis

TSX:CCL-B - Toronto Stock Exchange - CA1249003098 - Common Stock - Currency: CAD

81.48  +1.57 (+1.96%)

Fundamental Rating

5

CCL-B gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 9 industry peers in the Containers & Packaging industry. CCL-B scores excellent on profitability, but there are some minor concerns on its financial health. CCL-B is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CCL-B had positive earnings in the past year.
CCL-B had a positive operating cash flow in the past year.
CCL-B had positive earnings in each of the past 5 years.
In the past 5 years CCL-B always reported a positive cash flow from operatings.
CCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

With a decent Return On Assets value of 8.42%, CCL-B is doing good in the industry, outperforming 66.67% of the companies in the same industry.
The Return On Equity of CCL-B (15.73%) is better than 77.78% of its industry peers.
CCL-B has a Return On Invested Capital of 9.53%. This is in the better half of the industry: CCL-B outperforms 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CCL-B is in line with the industry average of 8.67%.
The 3 year average ROIC (9.32%) for CCL-B is below the current ROIC(9.53%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.42%
ROE 15.73%
ROIC 9.53%
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
CCL-B.CA Yearly ROA, ROE, ROICCCL-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 11.61%, CCL-B is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
CCL-B's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 14.83%, CCL-B is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
CCL-B's Operating Margin has been stable in the last couple of years.
The Gross Margin of CCL-B (29.68%) is comparable to the rest of the industry.
CCL-B's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.83%
PM (TTM) 11.61%
GM 29.68%
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
CCL-B.CA Yearly Profit, Operating, Gross MarginsCCL-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CCL-B is creating some value.
The number of shares outstanding for CCL-B has been reduced compared to 1 year ago.
Compared to 5 years ago, CCL-B has less shares outstanding
The debt/assets ratio for CCL-B has been reduced compared to a year ago.
CCL-B.CA Yearly Shares OutstandingCCL-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CCL-B.CA Yearly Total Debt VS Total AssetsCCL-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 3.72 indicates that CCL-B is not in any danger for bankruptcy at the moment.
CCL-B's Altman-Z score of 3.72 is fine compared to the rest of the industry. CCL-B outperforms 66.67% of its industry peers.
The Debt to FCF ratio of CCL-B is 3.97, which is a good value as it means it would take CCL-B, 3.97 years of fcf income to pay off all of its debts.
CCL-B has a worse Debt to FCF ratio (3.97) than 66.67% of its industry peers.
A Debt/Equity ratio of 0.46 indicates that CCL-B is not too dependend on debt financing.
CCL-B has a Debt to Equity ratio of 0.46. This is in the lower half of the industry: CCL-B underperforms 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.97
Altman-Z 3.72
ROIC/WACC1.36
WACC7%
CCL-B.CA Yearly LT Debt VS Equity VS FCFCCL-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 2.13 indicates that CCL-B has no problem at all paying its short term obligations.
With a Current ratio value of 2.13, CCL-B is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
CCL-B has a Quick Ratio of 1.55. This is a normal value and indicates that CCL-B is financially healthy and should not expect problems in meeting its short term obligations.
CCL-B's Quick ratio of 1.55 is in line compared to the rest of the industry. CCL-B outperforms 55.56% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.55
CCL-B.CA Yearly Current Assets VS Current LiabilitesCCL-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

CCL-B shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.23%, which is quite impressive.
Measured over the past years, CCL-B shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.99% on average per year.
CCL-B shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.80%.
CCL-B shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.37% yearly.
EPS 1Y (TTM)32.23%
EPS 3Y11.84%
EPS 5Y10.99%
EPS Q2Q%9.35%
Revenue 1Y (TTM)9.8%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%8.63%

3.2 Future

CCL-B is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.26% yearly.
The Revenue is expected to grow by 4.38% on average over the next years.
EPS Next Y-0.82%
EPS Next 2Y2.88%
EPS Next 3Y8.26%
EPS Next 5YN/A
Revenue Next Year5.18%
Revenue Next 2Y4.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCL-B.CA Yearly Revenue VS EstimatesCCL-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B
CCL-B.CA Yearly EPS VS EstimatesCCL-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 16.98, CCL-B is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of CCL-B indicates a slightly more expensive valuation: CCL-B is more expensive than 77.78% of the companies listed in the same industry.
CCL-B is valuated rather cheaply when we compare the Price/Earnings ratio to 27.48, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 16.38, CCL-B is valued correctly.
66.67% of the companies in the same industry are cheaper than CCL-B, based on the Price/Forward Earnings ratio.
CCL-B's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.52.
Industry RankSector Rank
PE 16.98
Fwd PE 16.38
CCL-B.CA Price Earnings VS Forward Price EarningsCCL-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CCL-B indicates a slightly more expensive valuation: CCL-B is more expensive than 77.78% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CCL-B indicates a slightly more expensive valuation: CCL-B is more expensive than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22
EV/EBITDA 10.42
CCL-B.CA Per share dataCCL-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The decent profitability rating of CCL-B may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.54
EPS Next 2Y2.88%
EPS Next 3Y8.26%

5

5. Dividend

5.1 Amount

CCL-B has a Yearly Dividend Yield of 1.61%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.01, CCL-B has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.34, CCL-B is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.61%

5.2 History

The dividend of CCL-B is nicely growing with an annual growth rate of 11.36%!
CCL-B has paid a dividend for at least 10 years, which is a reliable track record.
CCL-B has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.36%
Div Incr Years23
Div Non Decr Years34
CCL-B.CA Yearly Dividends per shareCCL-B.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

CCL-B pays out 24.59% of its income as dividend. This is a sustainable payout ratio.
CCL-B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP24.59%
EPS Next 2Y2.88%
EPS Next 3Y8.26%
CCL-B.CA Yearly Income VS Free CF VS DividendCCL-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CCL-B.CA Dividend Payout.CCL-B.CA Dividend Payout, showing the Payout Ratio.CCL-B.CA Dividend Payout.PayoutRetained Earnings

CCL INDUSTRIES INC - CL B

TSX:CCL-B (7/17/2025, 7:00:00 PM)

81.48

+1.57 (+1.96%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06
Inst Owners39.72%
Inst Owner ChangeN/A
Ins Owners1.91%
Ins Owner ChangeN/A
Market Cap14.26B
Analysts82.11
Price Target93.13 (14.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.61%
Yearly Dividend1.16
Dividend Growth(5Y)11.36%
DP24.59%
Div Incr Years23
Div Non Decr Years34
Ex-Date06-13 2025-06-13 (0.32)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.41%
Min EPS beat(2)-1.39%
Max EPS beat(2)4.21%
EPS beat(4)2
Avg EPS beat(4)10.9%
Min EPS beat(4)-5.47%
Max EPS beat(4)46.26%
EPS beat(8)3
Avg EPS beat(8)2.39%
EPS beat(12)5
Avg EPS beat(12)1.9%
EPS beat(16)8
Avg EPS beat(16)2.43%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.94%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)1.57%
Revenue beat(8)1
Avg Revenue beat(8)-1.9%
Revenue beat(12)2
Avg Revenue beat(12)-1.72%
Revenue beat(16)6
Avg Revenue beat(16)-1.07%
PT rev (1m)0%
PT rev (3m)0.55%
EPS NQ rev (1m)0.13%
EPS NQ rev (3m)-1.73%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.2%
Revenue NQ rev (3m)-0.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 16.98
Fwd PE 16.38
P/S 1.93
P/FCF 22
P/OCF 13.64
P/B 2.61
P/tB 8.17
EV/EBITDA 10.42
EPS(TTM)4.8
EY5.89%
EPS(NY)4.97
Fwd EY6.11%
FCF(TTM)3.7
FCFY4.55%
OCF(TTM)5.97
OCFY7.33%
SpS42.26
BVpS31.19
TBVpS9.98
PEG (NY)N/A
PEG (5Y)1.54
Profitability
Industry RankSector Rank
ROA 8.42%
ROE 15.73%
ROCE 12.66%
ROIC 9.53%
ROICexc 10.53%
ROICexgc 19.98%
OM 14.83%
PM (TTM) 11.61%
GM 29.68%
FCFM 8.76%
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
ROICexc(3y)10.42%
ROICexc(5y)10.66%
ROICexgc(3y)20.67%
ROICexgc(5y)21.9%
ROCE(3y)12.39%
ROCE(5y)12.67%
ROICexcg growth 3Y-4.22%
ROICexcg growth 5Y-2.39%
ROICexc growth 3Y-1.48%
ROICexc growth 5Y-0.08%
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
F-Score8
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.97
Debt/EBITDA 1.64
Cap/Depr 90.23%
Cap/Sales 5.37%
Interest Coverage 19.01
Cash Conversion 68.02%
Profit Quality 75.5%
Current Ratio 2.13
Quick Ratio 1.55
Altman-Z 3.72
F-Score8
WACC7%
ROIC/WACC1.36
Cap/Depr(3y)114.57%
Cap/Depr(5y)103.99%
Cap/Sales(3y)6.78%
Cap/Sales(5y)6.27%
Profit Quality(3y)87.06%
Profit Quality(5y)92.08%
High Growth Momentum
Growth
EPS 1Y (TTM)32.23%
EPS 3Y11.84%
EPS 5Y10.99%
EPS Q2Q%9.35%
EPS Next Y-0.82%
EPS Next 2Y2.88%
EPS Next 3Y8.26%
EPS Next 5YN/A
Revenue 1Y (TTM)9.8%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%8.63%
Revenue Next Year5.18%
Revenue Next 2Y4.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.05%
EBIT growth 3Y8.62%
EBIT growth 5Y7.62%
EBIT Next Year41.68%
EBIT Next 3Y15.95%
EBIT Next 5YN/A
FCF growth 1Y32.16%
FCF growth 3Y5.34%
FCF growth 5Y6.76%
OCF growth 1Y8.38%
OCF growth 3Y8.25%
OCF growth 5Y6.42%